Skip to content
Brilliant Blue Biosciences logoBrilliant BlueBiosciences
Articles

Papers, explained in our own words

Every entry summarises what the study set out to test, what it found and why it changes how we design delivery systems. Browse research and reviews or search the collection.

601 articles

Showing 1–1 of 1 articles · Keyword: glioma Clear keyword

Frontiers in immunology2026ReviewNon-viral Gene DeliveryDrug Delivery

1. Intranasal nano-immunotherapy for glioma: bypassing the blood-brain barrier, reprogramming the immune microenvironment, and bridging preclinical validation

Li L, Wu M, Li L

Glioma, particularly glioblastoma, remains difficult to treat because of limited drug penetration across the blood-brain barrier, profound immune suppression, and insufficient intracranial exposure of systemic immunotherapies. Intranasal nano-immunotherapy is being explored as a potential strategy that may integrate…

Read the article
Articles | Brilliant Blue Biosciences